HomeCompareATHX vs CL

ATHX vs CL: Dividend Comparison 2026

ATHX yields 14814.81% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ATHX wins by $2677980877459223040.00M in total portfolio value
10 years
ATHX
ATHX
● Live price
14814.81%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2677980877459223040.00M
Annual income
$2,642,887,894,030,851,000,000,000.00
Full ATHX calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — ATHX vs CL

📍 ATHX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodATHXCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ATHX + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ATHX pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATHX
Annual income on $10K today (after 15% tax)
$1,259,259.26/yr
After 10yr DRIP, annual income (after tax)
$2,246,454,709,926,223,300,000,000.00/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, ATHX beats the other by $2,246,454,709,926,223,300,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATHX + CL for your $10,000?

ATHX: 50%CL: 50%
100% CL50/50100% ATHX
Portfolio after 10yr
$1338990438729611520.00M
Annual income
$1,321,443,947,015,425,400,000,000.00/yr
Blended yield
98.69%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

ATHX
Analyst Ratings
6
Buy
1
Hold
1
Sell
Consensus: Buy
Altman Z
-152.6
Piotroski
2/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATHX buys
0
CL buys
0
No recent congressional trades found for ATHX or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricATHXCL
Forward yield14814.81%2.43%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$2677980877459223040.00M$40.8K
Annual income after 10y$2,642,887,894,030,851,000,000,000.00$5,401.96
Total dividends collected$2675658490367706112.00M$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: ATHX vs CL ($10,000, DRIP)

YearATHX PortfolioATHX Income/yrCL PortfolioCL Income/yrGap
1← crossover$1,492,181$1,481,481.48$11,012$312.01+$1.48MATHX
2$208,198,432$206,601,797.37$12,196$412.95+$208.19MATHX
3$27,163,301,697$26,940,529,375.29$13,599$549.66+$27163.29MATHX
4$3,314,004,807,579$3,284,940,074,762.82$15,288$736.64+$3314004.79MATHX
5$378,099,822,241,034$374,553,837,096,924.30$17,353$995.28+$378099822.22MATHX
6$40,342,336,842,848,056$39,937,770,033,050,150.00$19,926$1,357.80+$40342336842.83MATHX
7$4,025,655,551,654,171,600$3,982,489,251,232,324,000.00$23,194$1,873.82+$4025655551654.15MATHX
8$375,711,296,730,478,150,000$371,403,845,290,208,200,000.00$27,439$2,621.52+$375711296730478.13MATHX
9$32,797,180,774,179,380,000,000$32,395,169,686,677,763,000,000.00$33,088$3,727.38+$32797180774179380.00MATHX
10$2,677,980,877,459,223,000,000,000$2,642,887,894,030,851,000,000,000.00$40,806$5,401.96+$2677980877459223040.00MATHX

ATHX vs CL: Complete Analysis 2026

ATHXStock

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients, including those suffering from serious conditions with unmet medical needs. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. Athersys, Inc. was founded in 1995 and is headquartered in Cleveland, Ohio.

Full ATHX Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this ATHX vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATHX vs SCHDATHX vs JEPIATHX vs OATHX vs KOATHX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.